3rd Quarter - Report

AVENUE SOLUTIONS for MODERNA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7667 (117th), S. 4348 (117th), S. 3799 (117th), H.R. 6833 (117th), H.R. 5585 (117th), H.R. 6007 (117th), H.R. 7007 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.